🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Opioid Use Disorder (OUD)

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) NCT07171359NA1 site📍 Portland Washington State University · Tests: TMS Low-Dose, TMS High-Dose Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment NCT07342504NA1 site📍 Notre Dame University of Notre Dame · Tests: Brief opioid-informed alcohol treatment Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes NCT03923374n/a1 site📍 Pittsburgh Senthil Sadhasivam · Tests: Subutex / Buprenorphine, Fetal & Neonatal MRI, DNA/Genetic/Pharmacokenetic Blood Draws Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT NCT06969261NA2 sites📍 Philadelphia📍 Philadelphia University of Pennsylvania · Tests: Penny COPILOT Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families NCT06685003NA1 site📍 New York We The Village, Inc. · Tests: Digital Tutorial overview, Digital Tutorial plus training Materials, Digital Tutorial plus training Materials plus feed… Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD) NCT06160284Phase 11 site📍 New Haven Yale University · Tests: Psilocybin Mapping Ibogaine Neural Dynamics in Opioid Use Disorder NCT07226570n/a1 site📍 Irvine University of California, Irvine · Tests: Observational study with MRI/EEG Interpersonal Brain Function in Opioid Use NCT07386769NA1 site📍 La Jolla University of California, San Diego · Tests: Meditation, Psychoeducation Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD NCT06774248NA1 site📍 Baltimore Potomac Health Foundations · Tests: Youth Opioid Recovery Support (YORS) Opioid Adherence and Support Through Innovative Texting Strategies NCT07350148NA1 site📍 Albuquerque University of New Mexico · Tests: Mindfulness text messages Wellcome Leap Psilocybin for OUD NCT06786325Phase 21 site📍 Philadelphia Anna Rose Childress, Ph.D. · Tests: Psilocybin Focused Ultrasound for the Complex Patient NCT06453109NA1 site📍 Washington D.C. Washington D.C. Veterans Affairs Medical Center · Tests: low intensity focused ultrasound (LIFU) Ketones for Opioid Craving NCT07128524Phase 21 site📍 Wernersville University of Maryland, Baltimore · Tests: Treatment with Ketone Supplement, Treatment with Placebo Social Functioning in Opioid Use Disorder NCT07044466NA1 site📍 Charleston Medical University of South Carolina · Tests: CBT4CBT-Buprenorphine Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD NCT06718491NA1 site📍 Columbus Ohio State University · Tests: Managing Physical Reactions to Overwhelming Emotions (IMPROVE), Health Education Training (HET) Expanding Medication-Assisted Therapies in Central Asia NCT05579470NA4 sites📍 New Haven📍 Almaty📍 Bishkek Yale University · Tests: NIATx The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD) NCT06832007NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: AYO light glasses (experimental), AYO light glasses (comparator) Autonomous Methadone Delivery System by Nurses NCT07085377NA8 sites📍 Bayonne📍 Bordeaux📍 Brioude Hospices Civils de Lyon · Tests: DIADEME strategy, Controle strategy, Individual semi directive interview Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning NCT01730781n/a1 site📍 New Haven Yale University · Tests: [11-C]OMAR Psilocybin for Opioid Use Disorder (OUD) NCT06796062Phase 25 sites📍 Albuquerque📍 Albuquerque📍 Brooklyn NYU Langone Health · Tests: Psilocybin Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol NCT07269873Phase 11 site📍 Miami BioCorRx Pharmaceuticals Inc · Tests: BICX104 naltrexone implantable pellet, Bupropion 150 mg XL, Naltrexone (depot) E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder NCT05722561Phase 22 sites📍 New York📍 The Bronx NYU Langone Health · Tests: Telehealth Motivational Counseling, Nicotine Replacement Product, National Institute on Drug Abuse (NIDA) Standardized … OUD (Opioid Use Disorder) Target Trial NCT06585709NA1 site📍 Durham Duke University · Tests: Active repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive Transcranial Magnetic Stimulation (rTMS), H… Sensory Outcomes in Active Substance Users NCT06639438n/a1 site📍 Boston Boston Medical Center MDMA for Co-occurring PTSD and OUD After Childbirth NCT05219175Phase 21 site📍 Albuquerque University of New Mexico · Tests: MDMA Assisted Therapy Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder NCT07079826NA1 site📍 Pittsburgh Payel Roy · Tests: Sparrow Link (Active tAN), Sparrow Link (Sham tAN) Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions NCT06823453NA1 site📍 Chicago University of Illinois Chicago · Tests: Peer Harm Reduction Support Champion Intervention Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use NCT06379984Phase 21 site📍 Philadelphia University of Pennsylvania · Tests: Buprenorphine Combined THC and CBD for OUD and Chronic Pain NCT06544291Phase 21 site📍 New Haven Yale University · Tests: CBD 300mg, CBD 600mg, Placebo 0mg
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy